Literature DB >> 30938942

Targeting Autophagy in Obesity-Associated Heart Disease.

Diana Castañeda1, Mohanad Gabani2, Soo-Kyoung Choi3, Quynh My Nguyen4, Cheng Chen5, Ayesha Mapara6, Adam Kassan7, Alexis A Gonzalez8, Karima Ait-Aissa2, Modar Kassan2.   

Abstract

Over the past three decades, the increasing rates of obesity have led to an alarming obesity epidemic worldwide. Obesity is associated with an increased risk of cardiovascular diseases; thus, it is essential to define the molecular mechanisms by which obesity affects heart function. Individuals with obesity and overweight have shown changes in cardiac structure and function, leading to cardiomyopathy, hypertrophy, atrial fibrillation, and arrhythmia. Autophagy is a highly conserved recycling mechanism that delivers proteins and damaged organelles to lysosomes for degradation. In the hearts of patients and mouse models with obesity, this process is impaired. Furthermore, it has been shown that autophagy flux restoration in obesity models improves cardiac function. Therefore, autophagy may play an important role in mitigating the adverse effects of obesity on the heart. Throughout this review, we will discuss the benefits of autophagy on the heart in obesity and how regulating autophagy might be a therapeutic tool to reduce the risk of obesity-associated cardiovascular diseases.
© 2019 The Obesity Society.

Entities:  

Mesh:

Year:  2019        PMID: 30938942     DOI: 10.1002/oby.22455

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

Review 1.  Understanding the molecular mechanisms and role of autophagy in obesity.

Authors:  Tapan Behl; Aayush Sehgal; Rajni Bala; Swati Chadha
Journal:  Mol Biol Rep       Date:  2021-04-02       Impact factor: 2.316

2.  Increased Expression of Fibroblast Activation Protein is Associated with Autophagy Dysregulation and Oxidative Stress in Obese Women with Uterine Fibroids.

Authors:  Nashwa Maghraby; Amira M El Noweihi; Nagla T El-Melegy; Nashwa A M Mostafa; Ahmed M Abbas; Heba E M El-Deek; Eman Radwan
Journal:  Reprod Sci       Date:  2021-11-29       Impact factor: 3.060

3.  Measurement of autophagic flux in humans: an optimized method for blood samples.

Authors:  Julien Bensalem; Kathryn J Hattersley; Leanne K Hein; Xiao Tong Teong; Julian M Carosi; Sofia Hassiotis; Randall H Grose; Célia Fourrier; Leonie K Heilbronn; Timothy J Sargeant
Journal:  Autophagy       Date:  2020-12-11       Impact factor: 16.016

Review 4.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

5.  Compound LM9, a novel MyD88 inhibitor, efficiently mitigates inflammatory responses and fibrosis in obesity-induced cardiomyopathy.

Authors:  Xu-Yong Zheng; Chu-Chu Sun; Qian Liu; Xiao-Yao Lu; Li-Li Fu; Guang Liang; Xiu-Hua Zhang; Gao-Zhi Chen
Journal:  Acta Pharmacol Sin       Date:  2020-04-27       Impact factor: 6.150

6.  Parkin Insufficiency Accentuates High-Fat Diet-Induced Cardiac Remodeling and Contractile Dysfunction Through VDAC1-Mediated Mitochondrial Ca2+ Overload.

Authors:  Ne N Wu; Yaguang Bi; Amir Ajoolabady; Fei You; James Sowers; Qiurong Wang; Asli F Ceylan; Yingmei Zhang; Jun Ren
Journal:  JACC Basic Transl Sci       Date:  2022-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.